These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1719268)

  • 1. [The prognostic significance of serum alpha 1-fetoprotein in children and adolescents with malignant extracranial non-testicular germ cell tumors].
    Calaminus G; Vesterling-Hörner D; Bökkerink JP; Gadner H; Günther G; Haas HJ; Jürgens H; Teske C; Göbel U
    Klin Padiatr; 1991; 203(4):246-50. PubMed ID: 1719268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U
    Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T; Kawakita M; Terachi T; Habuchi T; Ogawa O; Kamoto T
    J Surg Oncol; 2006 Dec; 94(7):619-23. PubMed ID: 17111392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery in infants and children with testicular and paratesticular tumours: a single centre experience over a 25-year-period.
    Tröbs RB; Krauss M; Geyer C; Tannapfel A; Körholz D; Hirsch W
    Klin Padiatr; 2007; 219(3):146-51. PubMed ID: 17525908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of surgery, chemotherapy and irradiation on long term outcome of intracranial malignant non-germinomatous germ cell tumors: results of the German Cooperative Trial MAKEI 89.
    Calaminus G; Bamberg M; Jürgens H; Kortmann RD; Sörensen N; Wiestler OD; Göbel U
    Klin Padiatr; 2004; 216(3):141-9. PubMed ID: 15175958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improved prognosis of intracranial germ cell tumors by intensified therapy: results of the MAKEI 89 therapy protocol].
    Göbel U; Bamberg M; Calaminus G; Gnekow AK; Herrmann HD; Lenard HG; Spaar HJ; Niethammer D; Kühl J; Harms D
    Klin Padiatr; 1993; 205(4):217-24. PubMed ID: 7690863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-testicular germ cell tumors: analysis of the therapy study MAKEI 83/86 anc changes in the protocol for the follow-up study].
    Göbel U; Bamberg M; Haas RJ; Bökkerink JP; Brämswig G; Calaminus G; Engert J; Gadner H; Havers W; Janka-Schaub GE
    Klin Padiatr; 1989; 201(4):247-60. PubMed ID: 2476583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teratoma with malignant transformation: experiences of the cooperative GPOH protocols MAKEI 83/86/89/96.
    Biskup W; Calaminus G; Schneider DT; Leuschner I; Göbel U
    Klin Padiatr; 2006; 218(6):303-8. PubMed ID: 17080331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of alpha 1-fetoprotein and beta-human chorionic gonadotropin in infancy and childhood.
    Schneider DT; Calaminus G; Göbel U
    Pediatr Hematol Oncol; 2001; 18(1):11-26. PubMed ID: 11205836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-fetoprotein in the management of germ cell tumors of the ovary.
    Bonazzi C; Colombo N; Lissoni A; Pittelli MR; Bini S; Mangioni C
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):53-8. PubMed ID: 2480424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant germ cell tumours. Multicenter prospective trial in Polish Pediatric Group for Solid Tumours (years 1998-2000)].
    Popadiuk S; Korzon M; Szumera M; Chybicka A; Szmyd K; Dzierzega M; Kowalczyk JR; Wiśniewska-Slusarz H; Trelińska J; Wozniak W; Bilska K; Wysocki M; Krawczuk-Rybak M; Lopatka B
    Przegl Lek; 2004; 61 Suppl 2():29-32. PubMed ID: 15686043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".
    Lo Curto M; Lumia F; Alaggio R; Cecchetto G; Almasio P; Indolfi P; Siracusa F; Bagnulo S; De Bernardi B; De Laurentis T; Di Cataldo A; Tamaro P
    Med Pediatr Oncol; 2003 Nov; 41(5):417-25. PubMed ID: 14515380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastases in children and adolescents with extracranial germ cell tumor - data of the MAHO/MAKEI-registry.
    Göbel U; Schneider DT; Teske C; Schönberger S; Calaminus G
    Klin Padiatr; 2010 May; 222(3):140-4. PubMed ID: 20514616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.
    Toner GC; Geller NL; Tan C; Nisselbaum J; Bosl GJ
    Cancer Res; 1990 Sep; 50(18):5904-10. PubMed ID: 1697503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does serum tumor marker half-life complement pretreatment risk stratification in metastatic nonseminomatous germ cell tumors?
    Gerl A; Lamerz R; Clemm C; Mann K; Hartenstein R; Wilmanns W
    Clin Cancer Res; 1996 Sep; 2(9):1565-70. PubMed ID: 9816334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort.
    Wessalowski R; Blohm M; Calaminus G; Engert J; Harms D; Krause I; Kruck H; Grüttner HP; Pape H; Göbel U
    Klin Padiatr; 1997; 209(4):250-6. PubMed ID: 9293458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.